P Sandeep

Apollo Hospitals

Papers

1

Total Citations

5

H-Index

1

About

Dr. P Sandeep is a leading oncologic researcher whose work centers on advancing molecular imaging for prostate cancer management, with a particular focus on the clinical utility of Gallium-68 prostate-specific membrane antigen (PSMA) PET. Their major contributions include pioneering the correlation of PSMA PET-CT/MRI findings with histopathological characteristics in prostate cancer patients undergoing radical prostatectomy. This landmark 2025 study, already garnering 5 citations, provides critical prospective evidence validating the accuracy of PSMA PET for staging and detecting lymph node metastases—a key gap in the field. Dr. Sandeep’s research directly addresses the pressing need for non-invasive, reliable imaging to guide surgical planning and improve patient outcomes. By bridging radiology and pathology, their work has significant implications for precision oncology, helping to reduce unnecessary surgeries and optimize treatment strategies. Dr. Sandeep’s dedication to evidence-based imaging continues to shape clinical protocols, making them a vital contributor to the evolution of prostate cancer diagnostics and a valuable resource for students and clinicians alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Correlation of gallium-68 prostate-specific membrane antigen positron emission tomography – Computed tomography/magnetic resonance imaging with histopathology characteristics in carcinoma prostate patients undergoing radical prostatectomy
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Apollo Hospitals

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago